Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials

被引:17
作者
Liu, Jie [1 ]
Yuan, Feixiang [1 ]
Gao, Jian [2 ]
Shan, Boer [3 ]
Ren, Yulan [3 ]
Wang, Huaying [3 ]
Gao, Ying [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China
[2] Fudan Univ, Affiliated Zhongshan Hosp, Dept Nutr, Shanghai 200433, Peoples R China
[3] Fudan Univ, Shanghai Canc Ctr, Dept Female Tumor, Shanghai 200433, Peoples R China
关键词
isoflavone supplementation; endometrial thickness; meta-analysis; randomized controlled trials; Gerotarget; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; CANCER-RISK; SOY PROTEIN; DNA METHYLATION; CLINICAL-TRIALS; HOT FLUSHES; BONE LOSS; BREAST; PHYTOESTROGENS;
D O I
10.18632/oncotarget.7959
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Isoflavone from soy and other plants modulate hormonal effects in women, and the hormone disorder might result in different caners including endometrial cancer. However, it's effect on the risk of endometrial cancer is still inconclusive. We aimed to assess the effects of isoflavone on endometrial thickness, a risk factor of endometrial cancer in peri-and post-menopausal women. Methods: A meta-analysis of randomized controlled trials was conducted to evaluate the effect of oral isoflavone supplementation on endometrial thickness in peri-and post-menopausal women. Electronic searches were performed on the PubMed, Embase, the Cochrane Library, web of science, CINAHL, and WHO ICTRP to August 1st, 2015. Reviews and reference lists of relevant articles were also searched to identify more studies. Summary estimates of standard mean differences (SMD's) and 95% CIs were obtained with random-effects models. Heterogeneity was evaluated with meta-regression and stratified analyses. Results: A total of 23 trials were included in the current analysis. The overall results did not show significant change of endometrial thickness after oral isoflavone supplementation (23 studies, 2167subjects; SMD:-0.05; 95% CI:-0.23, 0.13; P=0.60). Stratified analysis suggested that a daily dose of more than 54mg could decrease the endometrial thickness for 0.26mm (10 trials, 984subjects; SMD:-0.26; 95% CI:-0.45, -0.07; P=0.007). Furthermore, isoflavone supplementation significantly decrease the endometrial thickness for 0.23mm in North American studies (7 trials, 726 subjects; SMD:-0.23; 95% CI:-0.44, -0.01; P=0.04), but it suggested an increase for 0.23mm in Asian studies (3 trials, 224 subjects; SMD: 0.23; 95% CI:-0.04, 0.50; P=0.10). Conclusion: Oral isoflavone supplementation might have different effects in different populations and at different daily doses. Multiple-centre, larger, and long-term trials are deserved to further evaluate its effect.
引用
收藏
页码:17369 / 17379
页数:11
相关论文
共 50 条
  • [21] Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials
    Harrington, Catherine A.
    English, Clayton
    PHARMACOTHERAPY, 2011, 31 (09): : 840 - 849
  • [22] Potassium supplementation and heart rate: A meta-analysis of randomized controlled trials
    Gijsbers, L.
    Moelenberg, F. J. M.
    Bakker, S. J. L.
    Geleijnse, J. M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2016, 26 (08) : 674 - 682
  • [23] Veterinary homeopathy: meta-analysis of randomised placebo-controlled trials
    Mathiel, Robert T.
    Clausen, Juergen
    HOMEOPATHY, 2015, 104 (01) : 3 - 8
  • [24] Effect of saffron supplementation on oxidative stress parameters: A systematic review and meta-analysis of randomized placebo-controlled trials
    Morvaridzadeh, Mojgan
    Agah, Shahram
    Dulce Estevao, M.
    Hosseini, Ava Sadat
    Heydari, Hafez
    Toupchian, Omid
    Abdollahi, Shima
    Persad, Emma
    Abu-Zaid, Ahmed
    Rezamand, Gholamreza
    Heshmati, Javad
    FOOD SCIENCE & NUTRITION, 2021, 9 (10): : 5809 - 5819
  • [25] Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: A Meta-analysis of Randomized, Placebo-controlled Trials
    Liu, Shan
    Hu, PengWei
    Du, Xiaoxin
    Zhou, Tao
    Pei, Xiaofang
    INDIAN PEDIATRICS, 2013, 50 (04) : 377 - 381
  • [26] Overactive Bladder Drugs and Constipation: A Meta-Analysis of Randomized, Placebo-Controlled Trials
    Patrick D. Meek
    Samuel D. Evang
    Mina Tadrous
    Dianne Roux-Lirange
    Darren M. Triller
    Bora Gumustop
    Digestive Diseases and Sciences, 2011, 56 : 7 - 18
  • [27] A meta-analysis of levetiracetam for randomized placebo-controlled trials in patients with refractory epilepsy
    Chen, Daye
    Bian, Hongliang
    Zhang, Lanlan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 : 905 - 917
  • [28] Oral Magnesium Supplementation for the Prevention of Preeclampsia: a Meta-analysis or Randomized Controlled Trials
    Yuan, Jing
    Yu, Ying
    Zhu, Tongyu
    Lin, Xiaohan
    Jing, Xincheng
    Zhang, Juan
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2022, 200 (08) : 3572 - 3581
  • [29] Oral Magnesium Supplementation for the Prevention of Preeclampsia: a Meta-analysis or Randomized Controlled Trials
    Jing Yuan
    Ying Yu
    Tongyu Zhu
    Xiaohan Lin
    Xincheng Jing
    Juan Zhang
    Biological Trace Element Research, 2022, 200 : 3572 - 3581
  • [30] Effects of Isoflavone Supplementation on the Response to Medroxyprogesterone in Premenopausal Women with Nonatypical Endometrial Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Vahedpour, Zahra
    Boroumand, Homa
    Tabatabaee Anaraki, Shirin
    Tabasi, Zohre
    Motedayyen, Hossein
    Akbari, Hossein
    Raygan, Fariba
    Ostadmohammadi, Vahidreza
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022